Table 1.
Participant characteristics. Data show 1median with interquartile range and Mean (SD). Values represent number of participants.
| Controls (n = 13)1 | Cases (n = 17)1 | P-value | |
|---|---|---|---|
| Age | 38 (33.0–49.0) | 41 (29–66.5) | 0.65 |
| Gender (M/F) | 6/7 | 9/8 | |
| BMI | 27.6 (5.0) | 36.5 (7.1) | 0.0007 |
| Fibrosis score | 4.1 (3.7–7.2) | 5.9 (5.5–9.1) | 0.0006 |
| Fibrosis stage | |||
|
F0-F1 F2 F3 F4 |
13 0 0 0 |
13 1 2 1 |
|
| Steatosis score | 211.5 (190.5–217.3) | 319.5 (277.5–355.0) | < 0.0001 |
| Steatosis stage | |||
|
S0 S1 S2 S3 |
13 0 0 0 |
0 4 3 10 |
|
| HbA1c | 7.1 (6.1–7.5) | 7.6 (6.8–7.9) | 0.094 |
| 24-h insulin dose | 45.5 (34.3–60) | 75.0 (54–127.8) | 0.004 |
P < 0.01.